Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. Operating Income
| Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Income | $5,646.0K | $124.4M | ($107.7M) | ($114.5M) | ($89.8M) | ($74.1M) | ($97.5M) | ($205.2M) | $457.7M | $760.0M | $838.4M | $1,251.9M | $1,330.7M | $2,079.6M | $2,534.4M | $2,209.8M | $3,576.6M | $8,946.8M | $4,738.9M | $4,047.1M |
Regeneron Pharmaceuticals, Inc. (REGN) Operating Income comparison analysis
REGN key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Regeneron Pharmaceuticals, Inc.'s Operating Income?
As of today, Regeneron Pharmaceuticals, Inc.'s last 12-month Operating Income is $4,004.4M, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Regeneron Pharmaceuticals, Inc.'s Operating Income growth rate?
Over the last year, Regeneron Pharmaceuticals, Inc.'s Operating Income growth was (5.1%). The average annual Operating Income growth rates for Regeneron Pharmaceuticals, Inc. have been 0.1% over the past three years, 12.2% over the past five years.
3) Is Regeneron Pharmaceuticals, Inc.'s Operating Income growth rate Good?
Over the last year, Regeneron Pharmaceuticals, Inc.'s Operating Income growth was (5.1%), which is lower than industry growth of (0.1%). It indicates that Regeneron Pharmaceuticals, Inc.'s Operating Income growth is Bad.